Clavis Pharma appoints Nicholas Adams as Chief Business Officer
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
List view / Grid view
11 July 2011 | By Citigate Dewe Rogerson
Clavis Pharma ASA, is pleased to announce the appointment of Nicholas Adams as Chief Business Officer...
11 July 2011 | By Eli Lilly and Company
Biopharmaceuticals be included in transatlantic trade and economic discussions...
11 July 2011 | By Sanofi
Sanofi and Genzyme announced positive top-line results...
11 July 2011 | By Sanofi
Sanofi announced the strategic divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International Inc...
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
7 July 2011 | By Sanofi
Sanofi announced that the company has discontinued the PALLAS Phase IIIb trial...
7 July 2011 | By Citigate Dewe Rogerson
Pharminox has completed a new round of equity funding, raising approximately £1.5m...
7 July 2011 | By The Scott Partnership
Sage-N, entered into an exclusive license agreement with the U.S. Army ECBC to commercialize a revolutionary new platform...
6 July 2011 | By The Scott Partnership
Two new scientific posters to be presented at the 2011 CRS meeting...
6 July 2011 | By Boehringer Ingelheim
The www.changemakers.com/morehealth competition launched...
5 July 2011 | By The Scott Partnership
Möbius electrophoretic mobility instrument can measure precise protein charges...
5 July 2011 | By Amgen
Amgen and UCB announced that they are collaborating with the NASA Ames Research Center to conduct a preclinical test...
5 July 2011 | By Pfizer
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208...
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
4 July 2011 | By GlaxoSmithKline
GlaxoSmithKline signed a long-term agreement with the World Anti-Doping Agency...